SCHEMBL15093307

SCHEMBL15093307

Nc1ccc2c(c1)c(-c1ccccc1)nc1cc(Oc3cc4c(cc3S(=O)(=O)O)-c3cc(S(=O)(=O)O)c(Oc5ccc6c(c5)nc(-c5ccccc5)c5cc(N)ccc56)cc3C4)ccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.40
▸ MEN1 O00255 3/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ MAPT P10636 3/20 0.40
▸ LMNA P02545 1/20 0.40
▸ GPR55 Q9Y2T6 1/20 0.40
▸ ACHE P22303 4/20 0.36
▸ L3MBTL1 Q9Y468 3/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ ATM Q13315 1/20 0.33
▸ TLR9 Q9NR96 1/20 0.33
▸ EGLN2 Q96KS0 2/20 0.32
▸ EGLN1 Q9GZT9 2/20 0.32
▸ CSNK2A2 P19784 3/20 0.32
▸ CSNK2B P67870 3/20 0.32
▸ POLB P06746 2/20 0.32
▸ APEX1 P27695 2/20 0.32
▸ RXFP1 Q9HBX9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15093295 0.96 KMT2A (0.38) KMT2AMEN1ALDH1A1MAPTLMNA
SCHEMBL14342934 0.83 KMT2A (0.52) KMT2AMEN1ALDH1A1MAPTLMNA
SCHEMBL15093342 0.80 NSD2 (0.32) NT5ENSD2CASP6
SCHEMBL14342956 0.79 KMT2A (0.49) KMT2AMEN1ALDH1A1MAPTLMNA
SCHEMBL15092880 0.78 PDPK1 (0.33) KMT2AMEN1ALDH1A1MAPTLMNA
SCHEMBL15093156 0.78 NT5E (0.36) KMT2AMEN1ALDH1A1MAPTLMNA
SCHEMBL15092915 0.77 MAPT (0.42) KMT2AMEN1ALDH1A1MAPTLMNA
SCHEMBL15092922 0.76 RAPGEF3 (0.35) KMT2AMEN1ALDH1A1MAPTLMNA
SCHEMBL15093076 0.75 MEN1 (0.36) KMT2AMEN1ALDH1A1MAPTL3MBTL1
SCHEMBL15093357 0.74 MAOB (0.41) KMT2AMEN1ALDH1A1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9156780-B2 Sulfonic acid group-containing diamine compound and method for producing the same NITTO DENKO CORPORATION (JP) 2015-10-13 — — US disclosed
US-9088030-B2 Polyimide, polyimide-based polymer electrolyte membrane, membrane-electrode assembly, and polymer electrolyte fuel cell NITTO DENKO CORPORATION (JP) 2015-07-21 — — US disclosed
EP-2692774-A1 POLYIMIDE, POLYIMIDE POLYMER ELECTROLYTE MEMBRANE, MEMBRANE ELECTRODE ASSEMBLY, AND SOLID POLYMER FUEL CELL Nitto Denko Corporation (JP) 2014-02-05 — — EP disclosed
EP-2692721-A1 DIAMINE COMPOUND CONTAINING SULFONIC ACID GROUP, AND METHOD FOR PRODUCING SAME Nitto Denko Corporation (JP) 2014-02-05 — — EP disclosed
US-20130288156-A1 POLYIMIDE, POLYIMIDE-BASED POLYMER ELECTROLYTE MEMBRANE, MEMBRANE-ELECTRODE ASSEMBLY, AND POLYMER ELECTROLYTE FUEL CELL NITTO DENKO CORPORATION (JP) 2013-10-31 — — US disclosed
US-20130178649-A1 SULFONIC ACID GROUP-CONTAINING DIAMINE COMPOUND AND METHOD FOR PRODUCING THE SAME NITTO DENKO CORPORATION (JP) 2013-07-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130178649-A1 SULFONIC ACID GROUP-CONTAINING DIAMINE COMPOUND AND METHOD FOR PRODUCING THE SAME SAT1, DAO, SRM KMT2A 1536/4885MEN1 238/4885ALDH1A1 279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback